NephroGenex Cash Flow - Quarterly (OTCMKTS:NRXGQ)

Add to My Stocks
$0 $0 (0%) NRXGQ stock closing price May 25, 2017 (Closing)

For analyzing any company like NephroGenex from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows NephroGenex profits, the balance sheet shows NephroGenex debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. NephroGenex stock analysis shows negative net income cash flow of $-22.86M till 2015 Q4. This statement is important because profits alone cannot pay employees, or bills. Cash is required. NephroGenex saw a inflow of $11.68M from investing activities till 2015 Q4.

View and download details of NephroGenex cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2015 Q4
Net Income Cash Flow
-22.86M
Depreciation Depletion Amortization Cash-Flow-
Net Increase (Decrease) in Assets Liabilities1.47M
Cash From (used in) Discontinued Operations-
Other Adjustments Net1.74M
Net Cash from (used by) Operating Activities
-19.63M
Increase (Decrease) in Prop Plant And Equipment-0.01M
Acquisition Disposition of Subsidiaires-
Increase (Decrease) in Investments11.72M
Other Cash Inflow (Outflow) from Investment Activities-0.02M
Net Cash from (used by) Investment Activities
11.68M
Issuance (Purchase) of Equity Shares14.77M
Issuance (Repayment) of Debt Securities-0.38M
Increase (Decrease) in Bank & Other Borrowings-
Payment of Dividends & Other Cash Distributions-
Other Cash from (used by) Financing Activities-1.57M
Net Cash from (used by) Financing Activities
12.8M
Effect of Exchange Rate Changes on Cash-
Net Change in Cash & Cash Equivalents
4.85M
Cash & Equivalents at Beginning of Year-
Cash & Equivalents at Year End18.83M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The NephroGenex stock price history and NephroGenex stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that NephroGenex is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - NephroGenex stock price movement.
  • NephroGenex decreased its cash from operating activities to $-19.63M till 2015 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a positive value of $11.68M for NRXGQ stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $12.8M for NephroGenex. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For NephroGenex Cash Flow

Quarterly Cash Flow Statements For NephroGenex Inc Peers

Fibrogen cash flow, Mesoblast cash flow, INSPYR THERPTCS cash flow